Artemisinin-ALA co-treatment could kill cancer cells and suppress tumour growth with fewer side effects

In the future, scientists want to further investigate the molecules and examine their capacity as predictive biomarkers of taxane-based radiochemotherapy

The MasSpec Pen is an innovative handheld instrument that gives surgeons precise diagnostic information about what tissue to cut or preserve

One approach to killing cancer stem cells involves using viruses that specifically target tumor cells

The study sets a precedent for co-administering this or related drugs and starting cancer therapy simultaneously, though such interventions would first require lengthy human trials

Broad inadequacies in a widespread biological concept that affects cancer research could be significantly deflecting the aim of such targeted drugs, according to a new study

GeneStrat is a genomic liquid biopsy test utilizing circulating tumor nucleic acids from plasma that is used by physicians to inform treatment of patients with non-small cell lung cancer

Drug zeroes in on mutated nuclear receptors found in cancer, leaves normal proteins alone

The emerging field of radiomics has the potential to improve precision medicine by non-invasively assessing the molecular and clinical characteristics of lung tumors

The NCI defines recurrence as cancer that returns after a patient has had no signs of out-of-control cell growth for at least a year